Explore why tau still lacks treatments despite its critical role in Alzheimer's disease and other tauopathies.

Key opportunities include rising demand for biologics characterization, driven by advancements in drug development and monoclonal antibody therapiesDublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Mass ...

DNA interaction could unlock targeted therapeuticsDid you know that every cell in our body has the same DNA inside ...

Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

A lawsuit against Instacart alleges that the mobile shopping giant fired a corporate employee for running for Congress, citing fears that some of her Democratic positions could lead to backlash from ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

By Brad Sorensen, CFA NASDAQ:YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial ...

Subscribe Login Register Log out My Profile Subscriber Services Search PGe NEWSLETTERS PG STORE ARCHIVES OBITUARIES JOBS PUBLIC NOTICES CLASSIFIEDS EVENTS PETS ...